Unosi
Search full-text
"Antonija Verhaz"
-
Efficasy and safety of ombitasvir/peritaprevir/ritonavir+ dasabuvir+ ribavirin in patients treated at the Clinic for infectious diseases, republica Srpska Banja Luka (2018-09)
A. Verhaz, Efficasy and safety of ombitasvir/peritaprevir/ritonavir+ dasabuvir+ ribavirin in patients treated at the Clinic for infectious diseases, republica Srpska Banja Luka, Sep, 2018 -
Novosti u dijagnostici i liječenju Hepatitisa C (2018-09)
A. Verhaz, Novosti u dijagnostici i liječenju Hepatitisa C, Sep, 2018 -
KOMPLIKACIJE VARIČELA U KLINICI ZA INFEKTIVNE BOLESTI UKC RS U ŠESTOGODIŠNJEM PERIODU 2012. – 2017. GODINE (2018-09)
A. Verhaz, O. Jović-Đokanović, KOMPLIKACIJE VARIČELA U KLINICI ZA INFEKTIVNE BOLESTI UKC RS U ŠESTOGODIŠNJEM PERIODU 2012. – 2017. GODINE, Sep, 2018 -
Rates of pregnancy and preterm birth in Central/Eastern Europe and neighboring countries – data from ECEE Networg Group (2018-09)
A. Verhaz, J. Kowalska, Rates of pregnancy and preterm birth in Central/Eastern Europe and neighboring countries – data from ECEE Networg Group, Sep, 2018 -
EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT (2018-09)
A. Verhaz, T. Roganović, T. Macanović-Kostić, EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT, Sep, 2018 -
DISTRIBUCIJA GENOTIPOVA HEPATITIS C VIRUSA U REPUBLICI SRPSKOJ: DESETOGODIŠNJE RETROSPEKTIVNO ISKUSTVO (2019-09)
A. Verhaz, DISTRIBUCIJA GENOTIPOVA HEPATITIS C VIRUSA U REPUBLICI SRPSKOJ: DESETOGODIŠNJE RETROSPEKTIVNO ISKUSTVO, Acta Med Sal 2019;49-Supplement 1: S1-S262, pp. 68 - 69, Sep, 2019 -
Suvremeni pristup liječenju kroničnog hepatitisa C u Republici Srpskoj / Contemporary approach to the treatment of chronic hepatitis C in Republic of Srpska (2019-10)
A. Verhaz, Z. Vuković, T. Macanović Kostić, Suvremeni pristup liječenju kroničnog hepatitisa C u Republici Srpskoj / Contemporary approach to the treatment of chronic hepatitis C in Republic of Srpska, Oct, 2019 -
Where are we with PrEP use in Central and Eastern Europe? – data from the ECEE Network Group (2019-11)
J. Begovac, A. Skrzat-Klapaczyńska, J. Kowalska, A. Verhaz, Where are we with PrEP use in Central and Eastern Europe? – data from the ECEE Network Group, EACS Conference 2019 Abstract Nr PE28/15, Nov, 2019 -
Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe (2019-11)
K. Kase, A. Skrzat-Klapaczyńska, J. Kowalska, A. Verhaz, Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe, EACS Conference 2019 Abstract Nr PE31/11, Nov, 2019 -
Regional Consultation for Developing Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030 (2021-06)
A. Verhaz, Regional Consultation for Developing Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030, Jun, 2021 -
Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)
J. Kowalska, D. Bursa, D. Jilich, S. Antonjak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, A. Verhaz, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, ePoster. PE4/18ecee.president@gmail.com, Oct, 2021 -
Protokoli za dijagnozu i menadžment suspektnih i potvrđenih slučajeva COVID-19, primjena odgovarajućih javnozdravstvenih mjera i terapijski protokoli i nje (2022)
A. Verhaz, Protokoli za dijagnozu i menadžment suspektnih i potvrđenih slučajeva COVID-19, primjena odgovarajućih javnozdravstvenih mjera i terapijski protokoli i nje, 2022 -
Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)
J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022 -
HIV Disease Metrics and COVID-19 infection severity and outcomes in People Living with HIV in Central and Eastern Europe (2023)
A. Verhaz, HIV Disease Metrics and COVID-19 infection severity and outcomes in People Living with HIV in Central and Eastern Europe, 2023 -
Optimizacija tretmana hepatocelularnog i karcinoma dojke (2023-03)
A. Verhaz, Optimizacija tretmana hepatocelularnog i karcinoma dojke, Pozvano predavanje Hepatocelulrni karcinom i virusni hepatitisi, Mar, 2023 -
Učestalost oksigenacionih poremećaja u cirozi jetre (2016-05)
Z. Mavija, M. Mavija, S. Grbić, A. Verhaz, M. Vučić, Učestalost oksigenacionih poremećaja u cirozi jetre, ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, Vol. 6, No. 1-2, pp. 91 - 96, May, 2016 -
Karakteristike oboljelih od gripe hospitalizovanih u Klinici za infektivne bolesti Univerzitetskog kliničkog centra Republike Srpske u periodu od 01.01. do 31.03.2019.godine (2019)
S. Ritan, T. Roganović, A. Verhaz, D. Kasapović, M. Petrović, V. Kapetanović, Karakteristike oboljelih od gripe hospitalizovanih u Klinici za infektivne bolesti Univerzitetskog kliničkog centra Republike Srpske u periodu od 01.01. do 31.03.2019.godine, ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, Vol. 9, No. 1-2, pp. 59 - 65, 2019 -
Tocilizumab u terapiji COVID19 infekcije-naša iskustva (2022)
T. Roganović, S. Ritan, A. Verhaz, S. Tadić, D. Tica, S. Manojlović, Tocilizumab u terapiji COVID19 infekcije-naša iskustva, ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, Vol. 10, 11, 12, No. 1-2-3, pp. 299 - 303, 2022 -
Measles in healthcare workers in Banja Luka during the epidemic in 2018 (2018-09)
T. Roganović, L. Pašić, V. Lucic-Samardzija, A. Verhaz, M. Petrović, S. Ritan, Measles in healthcare workers in Banja Luka during the epidemic in 2018, Sep, 2018 -
Diferencijalna dijagnoza HGBS-a i leptospiroza (2018-09)
S. Ritan, T. Roganović, A. Verhaz, D. Kasapović, M. Petrović, L. Pašić, Diferencijalna dijagnoza HGBS-a i leptospiroza, Sep, 2018